Powder & Bulk Solids is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Drug Maker Adding Large Granulation Equipment to Iowa Plant

Image courtesy of Sari O'Neal / Alamy Stock Photo animal_pharmaceuticals_stock_image.jpg
Representative image
Animal pharmaceuticals manufacturer AML Riverside revealed plans for a $11 million expansion project at its Fort Dodge, IA facility.

Animal pharmaceuticals manufacturer AML Riverside is gearing up to inject $11 million in an expansion of its Fort Dodge, IA production plant, the company told The Fort Dodge Messenger. 16 new roles will be created at the site through the investment.

The funds will be used to add a dispensing room, space for processing activities, and large granulation equipment, the newspaper’s coverage detailed. A company official said in the Messenger that AML Riverside’s decision to expand the site stems from a recent R&D project for a client.

Work on the plant is expected to reach completion in 2024.

AML Riverside is part of global contract research organization (CRO) and contract development and manufacturing organization (CDMO) Argenta Global. Earlier this month, Argenta named Matt Applegate as general manager of the Fort Dodge plant.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.